The circulating splice isoform of follistatin, distinct from the FS-288 form.
Also known as: FS-315 · FST-315
Part of the Growth hormone & IGF peptides cluster
Overview
Follistatin-315 (FS-315) is the longer of two follistatin isoforms generated by alternative splicing of the FST gene. Follistatin binds activin and related TGF-beta ligands, including myostatin. FS-315 is an investigational research protein, not authorized by Health Canada; this page is educational only.
Source & context
Biological / chemical source: Longer splice isoform of human follistatin (FST gene)
Primary research or clinical context: Investigational research protein; not authorized by Health Canada
Two isoforms
Alternative splicing of the FST transcript yields FS-288 and FS-315. FS-315 has an acidic C-terminal tail that lowers its affinity for cell-surface heparan sulfate, so it circulates more freely, whereas FS-288 binds tightly to cell surfaces. Both act by sequestering activin and related ligands.
Research interest and status
Because follistatin can bind myostatin, a negative regulator of muscle mass, it draws interest in muscle-biology research. Human data specific to administered follistatin proteins are limited. FS-315 is investigational, is not an approved drug in Canada, and this summary makes no therapeutic or performance claims.
FAQ about Follistatin-315
What is Follistatin-315?+
Follistatin-315 (FS-315) is the longer of two follistatin isoforms generated by alternative splicing of the FST gene. Follistatin binds activin and related TGF-beta ligands, including myostatin. FS-315 is an investigational research protein, not authorized by Health Canada; this page is educational only.
Is Follistatin-315 an approved medicine?+
Follistatin-315 is discussed here as a research / educational topic. Investigational research protein; not authorized by Health Canada. This is not medical advice.
What is the typical length of Follistatin-315?+
Follistatin-315 is commonly described as approximately 315 amino acids (Activin-binding glycoprotein isoform).

